After finding that the Johnson & Johnson vaccines triggered antibody cell formation to fight COVID-19, the European Medicines Agency (EMA) began to review the drug for emergency use authorization (EUA). Meanwhile, the company’s rivals Moderna and Pfizer have also applied for the authorization in Europe. Additionally, they are under review by Health Canada.  

Read more here.  

More on: